Cholesterol and atheroma lipids activate complement and stimulate granulocytes. A possible mechanism for amplification of ischemic injury in atherosclerotic states

The Journal of Laboratory and Clinical Medicine

Volumn 98, Issue 1, 1981, Pages 68-77

  Hammerschmidt, Dale E ^a   Greenberg, Charles S ^a   Yamada, Osamu ^a   Craddock, Philip R ^a   Jacob, Harry S ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ATHEROMA; ATHEROSCLEROSIS; CARDIOVASCULAR SYSTEM; COMPLEMENT ACTIVATION; ETIOLOGY; GRANULOCYTE; HUMAN CELL; IN VITRO STUDY;

ARTERIOSCLEROSIS; CHOLESTEROL; COMPLEMENT ACTIVATION; COMPLEMENT C5; CORONARY DISEASE; GRANULOCYTES; HUMANS; LIPIDS; SUPEROXIDES;

EID: 0019512097     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Granulocyte-complement interaction: a beneficial antimicrobial mechanism that can cause disease
2. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats
3. Imaging experimental myocardial infarction with indium-111-labeled autologous leukocytes: effects of infarct age and residual regional myocardial blood flow
4. The nitroblue tetrazolium test and acute myocardial infarction
5. Consumption of classical complement by heart subcellular membranes in vitro and in patients after acute myocardial infarction
6. Chemotactic activity in the coronary sinus after experimental myocardial infarction: effects of pharmacologic interventions on ischemic injury
7. Complement-induced granulocyte aggregation: an unsuspected mechanism of disease (Beth Israel Seminar)
8. Complement-induced granulocyte aggregation in vivo
9. Atheroma cholesterol activates complement and aggregates granulocytes: possible role in ischemic manifestations of atherosclerosis
10. Arterial occlusions produced by emboli from eroded aortic atheromatous plaques
11. Complement as a mediator of inflammation in acute gouty arthritis. Studies on the reaction between human serum complement and sodium urate crystals
12. Immunoglobulin G independent activation of the classical complement pathway to monosodium urate crystals
13. Spontaneously-occurring angiotoxic derivatives of cholesterol
14. Complement (C5a)-induced granulocyte aggregation in vitro: a possible mechanism of complement-mediated leukostasis and leukopenia
15. Effect of heparin on complement activation and lysis of paroxysmal nocturnal hemoglobinuria (PNH) red cells
16. Granulocyte aggregometry: a sensitive technique for the detection of C5a and complement activation
17. Complement activation and pulmonary leukostasis during nylon-fiber filtration leukapheresis
18. Isolation of mononuclear cells and granulocytes from blood. Isolation of mononuclear cells by one centrifugation and of granulocytes by combining centrifugation and sedimentation at Ig
19. Quantitative aspects of the production of superoxide radicals by phagocytizing human granulocytes
20. Oxygen radicals mediate endothelial damage by complement-stimulated granulocytes: an in vitro model of immune vascular damage
21. C3 shunt activation in human serum chelated with EGTA
22. Sulfinpyrazone in the prevention of cardiac death after myocardial infarction
23. Granulocyte aggregation as a manifestation of membrane interactions with complement
24. Cholesterol-dependent human complement activation resulting in damage to liposomal model membranes
25. Activation of human complement by liposomes: a model for membrane activation of the alternative pathway
26. Corticosteroids inhibit complement-induced granulocyte aggregation: a possible mechanism for their efficacy in shock states